International Journal of Laboratory Hematology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation
Int J Lab Hematol. 2024 Apr 10. doi: 10.1111/ijlh.14275. Online ahead of print.NO ABSTRACTPMID:38600651 | DOI:10.1111/ijlh.14275 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 11, 2024 Category: Hematology Authors: Song Xue Wenqiu Huang Yongping Zhang Fuhong Liu Qi Hao Jiajun Hu Lei Yuan Jingbo Wang Source Type: research

Construction and validation of key genes-related prognosis model in children with acute myeloid leukaemia
CONCLUSION: A prognosis-related gene model of AML was successfully constructed, and the expression levels of the model genes varied with AML stage.PMID:38600718 | DOI:10.1111/ijlh.14272 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 11, 2024 Category: Hematology Authors: Fan Huang Chuan Ming Yuqian Jiang Chenli Li Cheng Tan Source Type: research

Congenital sideroblastic anemia with vacuolated bone marrow precursors secondary to SLC25A38 mutation-A great mimicker of Pearson syndrome
Int J Lab Hematol. 2024 Apr 11. doi: 10.1111/ijlh.14282. Online ahead of print.NO ABSTRACTPMID:38604808 | DOI:10.1111/ijlh.14282 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 11, 2024 Category: Hematology Authors: Amiya Ranjan Nayak Pratyusha Gudapati Ganesh Kumar Viswanathan Jasmita Dass Mukul Aggarwal Source Type: research

Noncriteria antiphospholipid antibodies in antiphospholipid syndrome
Int J Lab Hematol. 2024 Apr 7. doi: 10.1111/ijlh.14268. Online ahead of print.ABSTRACTAntiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombotic manifestations and/or obstetric complications in patients with persistently positive antiphospholipid antibodies (aPL). aPL are a heterogeneous group of autoantibodies, but only lupus anticoagulant, anticardiolipin (aCL), and antibeta2-glycoprotein I antibodies (aβ2GPI) IgG or IgM are included as laboratory classification criteria. Seronegative APS patients are usually defined as patients with the clinical symptoms of APS but who test negative for aPL. T...
Source: International Journal of Laboratory Hematology - April 7, 2024 Category: Hematology Authors: Katrien M J Devreese Source Type: research